Recent News

• 03.06.2025 - Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.06.2025 - Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.18.2025 - Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
• 02.18.2025 - Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
• 01.30.2025 - Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
• 01.30.2025 - Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Recent Filings

• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 3 Initial statement of beneficial ownership of securities
• 02.18.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.07.2025 - 8-K Current report
• 01.07.2025 - EX-99.1 EX-99.1
• 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2025 - 3 Initial statement of beneficial ownership of securities
• 01.02.2025 - 424B3 Prospectus [Rule 424(b)(3)]